Reply to comment on "Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter"

J Formos Med Assoc. 2023:122 Suppl 1:S103-S104. doi: 10.1016/j.jfma.2023.08.004. Epub 2023 Aug 14.
No abstract available

Publication types

  • Letter